Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Farag Kameel D.. Officer active across 1 company, notably Akari Therapeutics Plc. Cumulatively, 12 reports have been published. History available since 22 October 2025. The latest transaction was disclosed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Farag Kameel D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
1,728 shares@ US$7.52American Depositary Shares representing Ordinary SharesSEC:0001493152-26-039246:0
1,130 shares@ US$11.500.095% mcap21.2% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-036231:0
1,248 sharesAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:0
1,395 sharesAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:1
1,570 sharesAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:2
2,539 sharesAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:3
3,725 sharesAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:4
7,353 sharesAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:5
1,000 sharesAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-030210:6
32,000 shares@ US$0.7554.6% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-25-020753:0
26,619 shares@ US$0.7545.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-25-020753:1
6,277 shares@ US$0.749.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-25-019194:0
About Farag Kameel D.
Farag Kameel D. is a declarant linked to Akari Therapeutics Plc, where the listed role is Interim CFO. The record shows 11 filings, and the sampled recent filings cover the period from 2025-10-24 to 2026-08-05, with a modal transaction nature of Attribution.